Cervomed Inc.

10/15/2024 | Press release | Distributed by Public on 10/15/2024 06:28

CervoMed Announces Last Patient Last Visit in Phase 2b RewinD LB Trial of Neflamapimod for the Treatment of Early Stage Dementia with Lewy Bodies (DLB)

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.